ReproCell Inc (4978)

Currency in JPY
130.0
+6.0(+4.84%)
Closed·
4978 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
123.0130.0
52 wk Range
117.0242.0
Key Statistics
Bid/Ask
129.00 / 130.00
Prev. Close
124
Open
124
Day's Range
123-130
52 wk Range
117-242
Volume
463.4K
Average Volume (3m)
562.72K
1-Year Change
-30.8511%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4978 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Liquid assets exceed short term obligations

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
May 14, 2026
EPS / Forecast
-1.40 / --
Revenue / Forecast
624M / --
EPS Revisions
Last 90 days

4978 Income Statement

Compare 4978 to Peers and Sector

Metrics to compare
4978
Peers
Sector
Relationship
P/E Ratio
−20.9x−8.4x−0.4x
PEG Ratio
0.03−0.150.00
Price/Book
1.4x2.6x2.6x
Price / LTM Sales
5.5x9.5x3.0x
Upside (Analyst Target)
-53.4%49.1%
Fair Value Upside
Unlock10.3%6.1%Unlock

ReproCELL Incorporated provides stem cell research and drug discovery services in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, feeder cells, pluripotent stem cells, StemEdit gene edited iPSCs, mesenchymal stem cells (MSCs), and new immortalized cell lines and related reagents; and iPSC-derived exosomes. The company also provides Alvetex 3D, a cell culture system; Alvetex, an advanced tissue bioengineering system; EZSPHERE Multiwell Dishes and Plates; KOKEN atelocollagen; ABLE Biott bioreactor systems; and 2mag stirrer systems. In addition, It offers research stem cell, genomics, clinical stem cell research, preclinical and drug discovery CRO, precision medicine, human tissue samples, clinical laboratory, and gene editing services. ReproCELL Incorporated was incorporated in 2003 and is based in Yokohama, Japan.

Employees
99
Market
Japan

FAQ

What Is the ReproCell (4978) Stock Price Today?

The ReproCell stock price today is 130.0 JPY.

What Stock Exchange Does ReproCell Trade On?

ReproCell is listed and trades on the Tokyo Stock Exchange.

What Is the Stock Symbol for ReproCell?

The stock symbol for ReproCell is "4978."

What Is the ReproCell Market Cap?

As of today, ReproCell market cap is 12.35B JPY.

What Is ReproCell's Earnings Per Share (TTM)?

The ReproCell EPS (TTM) is -6.2.

When Is the Next ReproCell Earnings Date?

ReproCell will release its next earnings report on Aug 06, 2026.

From a Technical Analysis Perspective, Is 4978 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has ReproCell Stock Split?

ReproCell has split 1 times.

How Many Employees Does ReproCell Have?

ReproCell has 99 employees.

What is the current trading status of ReproCell (4978)?

As of Jul 04, 2026, ReproCell (4978) is trading at a price of 130.0 JPY, with a previous close of 124.0 JPY. The stock has fluctuated within a day range of 123.0 JPY to 130.0 JPY, while its 52-week range spans from 117.0 JPY to 242.0 JPY.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.